The World Health Organization estimates that 350,000 people die each year worldwide of hepatitis C and its complications. Although this is not an epidemic, it is serious enough that health care professions are, and should be, alarmed and prepared. This session explores which patients should be considered high-risk and the implications of caring for someone who is experiencing those symptoms. Treatment, including pharmacotherapeutics, is included in the discussion of nursing and medical interventions.
Contact hours available until 9/29/2015.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure: Speaker(s) have no disclosures to declare.
Planning Committee members have no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
This educational activity has been co-provided by Anthony J. Jannetti, Inc. and Academy of Medical-Surgical Nurses.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC-COA)
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered nursing, Provider Number, CEP 5387.
Compare and contrast the incidence and the populations at risk for Hepatitis C.
Describe medical and nursing interventions and protocols.
MN, CMSRN, CPP,
Director of Education,
American Nephrology Nurses Association
Do Not Search
You must be logged in and own this session in order to